BFSG LLC’s ResMed RMD Stock Holding History

BFSG LLC’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.56M	Buy	18,267 +158	+0.9%	+$32.7K	0.32%	98
2026 Q1	$4.07M	Buy	18,109 +120	+0.7%	+$29.9K	0.38%	81
2025 Q4	$4.33M	Buy	17,989 +174	+1%	+$44.5K	0.42%	77
2025 Q3	$4.88M	Buy	17,815 +259	+1%	+$70.7K	0.47%	64
2025 Q2	$4.53M	Buy	17,556 +3	+0%	+$716	0.51%	62
2025 Q1	$3.93M	Sell	17,553 -9	-0.1%	-$2.1K	0.48%	73
2024 Q4	$4.02M	Buy	17,562 +395	+2%	+$95.1K	0.47%	75
2024 Q3	$4.19M	Sell	17,167 -166	-1%	-$37.1K	0.49%	73
2024 Q2	$3.32M	Buy	17,333 +381	+2%	+$77.3K	0.42%	82
2024 Q1	$3.36M	Buy	+16,952	New	+$3.11M	0.44%	80
2019 Q4	–	Sell	-3,901	Closed	-$527K	–	209
2019 Q3	$527K	Buy	+3,901	New	+$511K	0.12%	143

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BFSG LLC's RMD Position: Q2 2026 in Review

BFSG LLC increased its ResMed (RMD) stake by 0.87% in Q2 2026, buying an estimated $32.7K and bringing the position to 18,267 shares worth $3.56M. The position accounts for 0.32% of the portfolio, ranked #98.

BFSG LLC first reported a position in RMD in Q3 2019 and has held it in 11 quarters since. The position peaked at $4.88M in Q3 2025. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

BFSG LLC held 18,267 shares of ResMed worth $3.56M as of Q2 2026.
BFSG LLC bought 158 ResMed shares in Q2 2026, an estimated $32.7K.
ResMed made up 0.32% of BFSG LLC's portfolio in Q2 2026, its #98 holding.
BFSG LLC first reported a position in ResMed in Q3 2019 and has held it in 11 quarters since.
BFSG LLC's ResMed position peaked at $4.88M in Q3 2025.
887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on BFSG LLC's 13F filing for Q2 2026, filed 20 Jul 2026.